Digital Pathology Market By Type (Human and Veterinary); By Offering (Software (Pathology Management System, Laboratory Information System, & Others), Hardware (Diagnostic Scanners, Laboratory Components, Histology equipment, & Others), Support & Technical services, Others); By Application (Drug Discovery, Disease Diagnosis, Teleconsultation, Training & Education, and Others); By End Users (Research Institutions, Pathology Laboratories, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Medical Centers (Education), Clinical Labs, Geology, Hospitals, and Others); By Region (North America (U.S., Canada, Mexico, & Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden & Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), & Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore & Rest of Southeast Asia), & Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, & Rest of Middle East & Africa) Latin America (Brazil, Argentina, & Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
In the global digital pathology market, the major driver contributing to the market growth is increasing adoption of digital pathology to enhance lab efficiency. Digital pathology helps pathologists to improve lab efficiency as it decreases turnaround times, reduces costs, and provides healthcare professionals with access to subject-matter expertise. Improvements in lab efficiency helps both patients as well physicians to draw faster and more accurate lab results for diagnostic decisions based on diagnostic tests. Access to digital slides via web services enhances convenience and enables timely access to data. Moreover, it also enables patients to download the reports of tests if digital pathology is being used by pathologist. Market participants are investing in innovative marketing strategies to increase their customer base. For instance, in April 2021, Royal Philips collaborated with the Israeli company, Ibex Medical Analytics, to jointly promote their digital pathology and artificial intelligence (AI) solutions to hospitals, health networks, and pathology labs worldwide.
High cost of digital pathology systems is restraining the growth of global digital pathology market. Large hospitals with significant capital budgets can afford the deployment of pathology systems. However, pathologists and academic institutes with limited budgets or information technology (IT) support cannot always afford them. Moreover, in addition to high costs, lack of skilled professionals to operate the advanced digital pathology systems, also limits the market growth as many medical institution hesitate to adopt these systems.
Digital pathology is defined as a sub-field of pathology whose purpose is data management based on information that has been generated from digitized specimen slides. Using computer-based technology, digital pathology utilizes virtual microscopy. Here, glass slides are converted into digital slides that can be viewed, managed, shared and analyzed on computer with the results getting displayed on monitor. Digital pathology is meant to improve operational efficiency, minimize laboratory expenses, increase productivity, aid the informed decision-making regarding treatment, and ensure patient care. In simple words, digital pathology interprets pathology information generated from a digitized glass slide. Digital slides are created by capturing glass slides with a scanning device so that a high-resolution digital image can be provided when the pathologist views the slide on a screen or mobile device. Investments towards technological advancement in the global digital pathology market is anticipated to supplement the growth over the forecast period. In September 2021, for instance, Agilent Technologies signed a worldwide distribution agreement with Visiopharm that enabled Agilent Technologies to co-market Visiopharm’s portfolio of CE-IVD marked AI-driven precision pathology software. The terms of agreement also allowed the sales of Agilent’s portfolio of automated pathology staining solutions.
The China-originated coronavirus pandemic accelerated the adoption of digital pathology in not only USA, but also in many other countries. The reasons for rapid adoption included the need to deal with higher case volume, need for pathologists to work from home due to government orders, and changes in regulatory requirements as well as governance. Amidst the COVID-19 pandemic, the use of digital tools has increased substantially in the healthcare sector. According to reports, the number of pathologists using whole slide imaging (WSI) for primary diagnosis increased from62.5%to 90.6%. Digital pathology can safeguard clinical services and pathology-based research in the current climate, while also keeping them safe for future references. The digital-based approach to diagnosis aids easy and efficient evaluation of surgical pathology slides from formalin-fixed paraffin-embedded tissue (FFPE). It also frees the pathologist from the constraints of using an optical microscope in their laboratory. Hence, global digital pathology market has growth potential in the pandemic. The lockdowns implemented to curb the rapid spread of coronavirus along with various restrictions related to social distancing, has led to an increased demand for digital pathology solutions, which enable pathologists to remotely view diagnostic results and draw primary diagnosis. In order to gain a competitive edge and deliver quick services, many pathologists and pathology labs are adopting digital pathology tools. The pandemic, hence, showcases positive growth prospects for global digital pathology market over the future years.
In September 2021, Quanterix received label expansion on emergency use authorization for COVID Antigen Test. The technology they are using in this test is called Simoa. The scientific name of this antigen is SARS-CoV-2 N Protein Antigen. The new test from Quanterix has been validated to be able to detect all variants of concern regarding coronavirus designated by Centers for Disease Control and Prevention (CDC), including Delta variant. The use of this test has been authorized in saliva samples. The Simoa technology has Examination Under Anaesthetic (EUA) label which serves as an additional evidence about its potential across range of clinical tests (primarily pathological in nature) that are less-invasive in nature.
New technological advances for image analysis is estimated to further accelerate the growth of global digital pathology market over the forecast period. Advanced ways of image analysis offer many advantages such as higher consistency, lesser interobserver discrepancy, and improved efficiency. The amount of information included in whole-slide imaging (WSI) presents tremendous new opportunities for developing as well as evaluating new and more effective treatments that ensure much better care of cancer patients and patients suffering from other diseases that can be life-threatening, if not diagnosed properly. As image analysis algorithms in digital pathology are still under research, many challenging problems and open questions involving them are being considered by medical experts. Such considerations include image quality, development of image processing, calibration & optimizing display, and machine learning (ML) methods for computer-aided diagnostic systems. Their validation of image analysis algorithms in digital pathology for diagnostic use is another concern. Research on these concern can be a new opportunity in the global digital pathology market. Multiplexing is another opportunity that can grow with global digital pathology market. In multiplexing, multiple protein and similar species antibodies are localized in a single section from the same sample. As multiplexing aids the localization of proteins of interest, several aspects of a cell can be measured due to the concurrent association of proteins with cell compartments or cell types. Hence, the demand for multiplexing service can increase with the growth of global digital pathology market. Virtual microscopy and WSI can be more helpful to pathologists compared to conventional microscopy as they allow the storage and fast dissemination of image data not only in pathology, but also in other biomedical areas. Hence, demand as well as market for virtual microscopy and WSI can also rise with global digital pathology market growth. Electronic health records (EHR) are also helpful in areas where pathology is required. They ensure better patient care, easy access for reference, and more convenience for physicians. As the EHR platforms allow healthcare professionals to share information in real-time, the demand and market for EHR service can grow with global digital pathology market growth. AI can also provide efficiency to digital pathology with regards to diagnosing different kinds of cancer or triaging biopsies. Hence, the role of AI can increase in medical sector with global digital pathology market growth.
In September 2021, Keen Eye launched its next-gen platform that could accelerate clinical trials with AI-powered Digital Pathology. This platform can enable compliance with good clinical & laboratory practices on full scale. With unprecedented efficiency, it can facilitate digital image analysis in the context of clinical trials, as in College of American Pathologists (CAP)/Clinical Laboratory Improvement Amendments (CLIA) laboratories.
In terms of revenue, digital pathology market was valued at US$ 823.38 Mn in 2020 growing at a CAGR of 10.1% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Digital Pathology Market Revenue & Forecast, (US$ Million), 2015 – 2029
Type Outlook:
On the basis of type, global digital pathology market has been segmented into human pathology and veterinary pathology. Human pathology accounted for the largest market share in digital pathology market in 2020 and during the forecast period (2021 – 2029), this segment is estimated to become the fastest growing market segment because human healthcare sector is a bigger market compared to veterinary healthcare sector.In August 2021, a global low-code Software as a Service (SaaS) company called Xybion Corporation released Pristima XD Digital Pathology. Through this software-based technology, Xybion Corporation intends to present the first of its kind preclinical laboratory information system that is not only fully integrated into the digital pathology workflow, but also provides efficient pathological studies of whole slides.
Offering Outlook:
In the context of offering, the global digital pathology market has been primarily segmented into software, hardware, support & technical services, and others. The software category has been further segmented into pathology management system, laboratory information system, and others. The hardware category has been further segmented into diagnostic scanners, laboratory components, histology equipment, and others. Hardware segment accounted for the largest market share in 2020. Among all the segments of hardware, diagnostic scanners category occupied the largest market share due to the increasing demand for digital pathology solutions and innovations in scanning technology. In August 2020, digital clinical pathology company, Techcyte closed a US$ 21 million financing round. With the funds received, Techcyt started to upgrade its clinical pathology platform for digital slide management and bring advanced diagnostic scanners to aid image analysis.
Application Outlook:
On the basis of application, the global digital pathology market has been segmented into disease diagnosis, drug discovery, training & education, teleconsultation, and others. Drug discovery segment held the largest market share in this market in 2020. During the forecast period, the disease diagnosis segment is estimated to witness highest growth rate due to the increasing prevalence of chronic diseases. The focus of manufacturers on the development of novel and rapid diagnostic techniques is also boosting the segment’s growth in the global market. Digital technologies can not only improve each step in diagnostic but they can also easily share information within inter or intra-departments. Cancer cell detection is expected to raise demand for disease diagnosis due to high prevalence of the different types of cancers and ongoing research initiatives.
End Users Outlook:
Considering the end users, the global digital pathology market has been segmented into research institutions, pathology laboratories, pharmaceutical & biotechnology companies, contract research organizations, academic medical centers (education), clinical labs, geology, hospitals, and others. The hospitals segment was the largest market segment in 2020. Hospitals have been the traditional sources of medical tests since the beginning of medical science. Due to coronavirus, many hospitals have started investing in advanced solutions, which has enabled them to cater a larger customer base and produce efficient outcome.
Region Outlook:
Based on the regions, North America accounted for a significant share in the digital pathology market in 2020. However, during the forecast period, the Asia Pacific region is expected to become the fastest growing regional market due to the need for efficient as well as cost-effective equipment, rising desire for innovative treatment alternatives, increasing prevalence of cancer, improved patient care facilities, and rising healthcare expenditure. Growth in healthcare infrastructure in countries like China, India, Japan, South Korea, and Singapore is also boosting the market growth in this region. Due to population growth in countries like China and India, the demand for healthcare systems including digital pathology is increasing. Implementation of digital healthcare applications and electronic health records (EHR) is slowly taking place in Asian countries that have better healthcare facilities compared to others. Growing trend of telehealth and mobile health is boosting markets in countries like Japan, South Korea, Singapore, and India.
Competitive Landscape
The report provides both, qualitative as well as quantitative research of global digital pathology market. It also provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as affiliations, collaborations, mergers & acquisitions (M&A), and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the digital pathology market are 3DHISTECH Ltd., Apollo Enterprise Imaging Corp., Corista, F. Hoffmann-La Roche Ltd, Hamamatsu Photonics K.K., Halo AP, Huron Technologies International Inc., Indica Labs, Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, OLYMPUS CORPORATION, OptraSCAN Inc., Proscia Inc., Sectra AB, Visiopharm A/S., and XIFIN Inc., amongst other market participants.
Global Digital Pathology Market:
By Type
- Human
- Veterinary
By Offering
- Software
- Pathology Management System
- Laboratory Information System
- Others
- Hardware
- Diagnostic Scanners
- Laboratory Components
- Histology equipment
- Others
- Support and Technical services
- Others
By Application
- Drug Discovery
- Disease Diagnosis
- Teleconsultation
- Training & Education
- Others
By End Users
- Research Institutions
- Pathology Laboratories
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic Medical Centers (Education)
- Clinical Labs
- Geology
- Hospitals
- Others
By Region
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Digital Pathology Market
6. Market Synopsis:
Digital Pathology Market
7. Digital Pathology Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Digital Pathology Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Digital Pathology Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Digital Pathology Market
8. Global Digital Pathology Market Analysis and Forecasts, 2021
– 2029
8.1. Overview
8.1.1. Global
Digital Pathology Market Revenue (US$ Mn)
8.2. Global
Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1. Human
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2020
8.2.1.3. Market Forecast, 2021 - 2029
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2020
8.2.1.5.1.2. Market
Forecast, 2021 - 2029
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2020
8.2.1.5.2.2. Market
Forecast, 2021 - 2029
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2020
8.2.1.5.3.2. Market
Forecast, 2021 - 2029
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2020
8.2.1.5.4.2. Market
Forecast, 2021 - 2029
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2020
8.2.1.5.5.2. Market
Forecast, 2021 - 2029
8.2.2. Veterinary
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2020
8.2.2.3. Market Forecast, 2021 - 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.3. Key
Segment for Channeling Investments
8.3.1. By Type
9. Global Digital Pathology Market Analysis and Forecasts, 2021
– 2029
9.1. Overview
9.2. Global
Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Offering
9.2.1. Software
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Pathology Management System,
Laboratory Information System, Others)
9.2.1.1. Pathology Management System
9.2.1.2. Laboratory Information System
9.2.1.3. Others
9.2.2. Hardware
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Diagnostic Scanners, Laboratory
Components, Histology equipment, Others)
9.2.2.1. Diagnostic Scanners
9.2.2.2. Laboratory Components
9.2.2.3. Histology equipment
9.2.2.4. Others
9.2.3. Support
and Technical services
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2020
9.2.3.3. Market Forecast, 2021 - 2029
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2020
9.2.3.5.1.2. Market
Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2020
9.2.3.5.2.2. Market
Forecast, 2021 - 2029
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2020
9.2.3.5.3.2. Market
Forecast, 2021 - 2029
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2020
9.2.3.5.4.2. Market
Forecast, 2021 - 2029
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2020
9.2.3.5.5.2. Market
Forecast, 2021 - 2029
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2020
9.2.4.3. Market Forecast, 2021 - 2029
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2020
9.2.4.5.1.2. Market
Forecast, 2021 - 2029
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2020
9.2.4.5.2.2. Market
Forecast, 2021 - 2029
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2020
9.2.4.5.3.2. Market
Forecast, 2021 - 2029
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2020
9.2.4.5.4.2. Market
Forecast, 2021 - 2029
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2020
9.2.4.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By
Offering
10. Global Digital Pathology Market Analysis and Forecasts, 2021
– 2029
10.1. Overview
10.2. Global
Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1. Drug
Discovery
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2020
10.2.1.5.1.2. Market
Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2020
10.2.1.5.2.2. Market
Forecast, 2021 - 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2020
10.2.1.5.3.2. Market
Forecast, 2021 - 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2020
10.2.1.5.4.2. Market
Forecast, 2021 - 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2020
10.2.1.5.5.2. Market
Forecast, 2021 - 2029
10.2.2. Disease
Diagnosis
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2020
10.2.2.5.1.2. Market
Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2020
10.2.2.5.2.2. Market
Forecast, 2021 - 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2020
10.2.2.5.3.2. Market
Forecast, 2021 - 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2020
10.2.2.5.4.2. Market
Forecast, 2021 - 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2020
10.2.2.5.5.2. Market
Forecast, 2021 - 2029
10.2.3. Teleconsultation
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2020
10.2.3.3. Market Forecast, 2021 - 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2020
10.2.3.5.1.2. Market
Forecast, 2021 - 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2020
10.2.3.5.2.2. Market
Forecast, 2021 - 2029
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2020
10.2.3.5.3.2. Market
Forecast, 2021 - 2029
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2020
10.2.3.5.4.2. Market
Forecast, 2021 - 2029
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2020
10.2.3.5.5.2. Market
Forecast, 2021 - 2029
10.2.4. Training
and Education
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2020
10.2.4.3. Market Forecast, 2021 - 2029
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2020
10.2.4.5.1.2. Market
Forecast, 2021 - 2029
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2020
10.2.4.5.2.2. Market
Forecast, 2021 - 2029
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2020
10.2.4.5.3.2. Market
Forecast, 2021 - 2029
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2020
10.2.4.5.4.2. Market
Forecast, 2021 - 2029
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2020
10.2.4.5.5.2. Market
Forecast, 2021 - 2029
10.2.5. Others
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2020
10.2.5.3. Market Forecast, 2021 - 2029
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2015 - 2020
10.2.5.5.1.2. Market
Forecast, 2021 - 2029
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 - 2020
10.2.5.5.2.2. Market
Forecast, 2021 - 2029
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2015 - 2020
10.2.5.5.3.2. Market
Forecast, 2021 - 2029
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 - 2020
10.2.5.5.4.2. Market
Forecast, 2021 - 2029
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2015 - 2020
10.2.5.5.5.2. Market
Forecast, 2021 - 2029
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. Global Digital Pathology Market Analysis and Forecasts, 2021
– 2029
11.1. Overview
11.2. Global
Digital Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Research
Institutions
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2020
11.2.1.3. Market Forecast, 2021 - 2029
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2020
11.2.1.5.1.2. Market
Forecast, 2021 - 2029
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2020
11.2.1.5.2.2. Market
Forecast, 2021 - 2029
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2020
11.2.1.5.3.2. Market
Forecast, 2021 - 2029
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2020
11.2.1.5.4.2. Market
Forecast, 2021 - 2029
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2020
11.2.1.5.5.2. Market
Forecast, 2021 - 2029
11.2.2. Pathology
Laboratories
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2020
11.2.2.3. Market Forecast, 2021 - 2029
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2020
11.2.2.5.1.2. Market
Forecast, 2021 - 2029
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2020
11.2.2.5.2.2. Market
Forecast, 2021 - 2029
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2020
11.2.2.5.3.2. Market
Forecast, 2021 - 2029
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2020
11.2.2.5.4.2. Market
Forecast, 2021 - 2029
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2020
11.2.2.5.5.2. Market
Forecast, 2021 - 2029
11.2.3. Pharmaceutical
and Biotechnology Companies
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2020
11.2.3.3. Market Forecast, 2021 - 2029
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2020
11.2.3.5.1.2. Market
Forecast, 2021 - 2029
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2020
11.2.3.5.2.2. Market
Forecast, 2021 - 2029
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2020
11.2.3.5.3.2. Market
Forecast, 2021 - 2029
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2020
11.2.3.5.4.2. Market
Forecast, 2021 - 2029
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2020
11.2.3.5.5.2. Market
Forecast, 2021 - 2029
11.2.4. Contract
Research Organizations
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2020
11.2.4.3. Market Forecast, 2021 - 2029
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2020
11.2.4.5.1.2. Market
Forecast, 2021 - 2029
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2020
11.2.4.5.2.2. Market
Forecast, 2021 - 2029
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2020
11.2.4.5.3.2. Market
Forecast, 2021 - 2029
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2020
11.2.4.5.4.2. Market
Forecast, 2021 - 2029
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2020
11.2.4.5.5.2. Market
Forecast, 2021 - 2029
11.2.5. Academic
Medical Centers (Education)
11.2.5.1. Definition
11.2.5.2. Market Estimation and Penetration, 2015 - 2020
11.2.5.3. Market Forecast, 2021 - 2029
11.2.5.4. Compound Annual Growth Rate (CAGR)
11.2.5.5. Regional Bifurcation
11.2.5.5.1. North America
11.2.5.5.1.1. Market
Estimation, 2015 - 2020
11.2.5.5.1.2. Market
Forecast, 2021 - 2029
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 - 2020
11.2.5.5.2.2. Market
Forecast, 2021 - 2029
11.2.5.5.3. Asia Pacific
11.2.5.5.3.1. Market
Estimation, 2015 - 2020
11.2.5.5.3.2. Market
Forecast, 2021 - 2029
11.2.5.5.4. Middle East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 - 2020
11.2.5.5.4.2. Market
Forecast, 2021 - 2029
11.2.5.5.5. Latin America
11.2.5.5.5.1. Market
Estimation, 2015 - 2020
11.2.5.5.5.2. Market
Forecast, 2021 - 2029
11.2.6. Clinical
Labs
11.2.6.1. Definition
11.2.6.2. Market Estimation and Penetration, 2015 - 2020
11.2.6.3. Market Forecast, 2021 - 2029
11.2.6.4. Compound Annual Growth Rate (CAGR)
11.2.6.5. Regional Bifurcation
11.2.6.5.1. North America
11.2.6.5.1.1. Market
Estimation, 2015 - 2020
11.2.6.5.1.2. Market
Forecast, 2021 - 2029
11.2.6.5.2. Europe
11.2.6.5.2.1. Market
Estimation, 2015 - 2020
11.2.6.5.2.2. Market
Forecast, 2021 - 2029
11.2.6.5.3. Asia Pacific
11.2.6.5.3.1. Market
Estimation, 2015 - 2020
11.2.6.5.3.2. Market
Forecast, 2021 - 2029
11.2.6.5.4. Middle East and Africa
11.2.6.5.4.1. Market
Estimation, 2015 - 2020
11.2.6.5.4.2. Market
Forecast, 2021 - 2029
11.2.6.5.5. Latin America
11.2.6.5.5.1. Market
Estimation, 2015 - 2020
11.2.6.5.5.2. Market
Forecast, 2021 - 2029
11.2.7. Geology
11.2.7.1. Definition
11.2.7.2. Market Estimation and Penetration, 2015 - 2020
11.2.7.3. Market Forecast, 2021 - 2029
11.2.7.4. Compound Annual Growth Rate (CAGR)
11.2.7.5. Regional Bifurcation
11.2.7.5.1. North America
11.2.7.5.1.1. Market
Estimation, 2015 - 2020
11.2.7.5.1.2. Market
Forecast, 2021 - 2029
11.2.7.5.2. Europe
11.2.7.5.2.1. Market
Estimation, 2015 - 2020
11.2.7.5.2.2. Market
Forecast, 2021 - 2029
11.2.7.5.3. Asia Pacific
11.2.7.5.3.1. Market
Estimation, 2015 - 2020
11.2.7.5.3.2. Market
Forecast, 2021 - 2029
11.2.7.5.4. Middle East and Africa
11.2.7.5.4.1. Market
Estimation, 2015 - 2020
11.2.7.5.4.2. Market
Forecast, 2021 - 2029
11.2.7.5.5. Latin America
11.2.7.5.5.1. Market
Estimation, 2015 - 2020
11.2.7.5.5.2. Market
Forecast, 2021 - 2029
11.2.8. Hospitals
11.2.8.1. Definition
11.2.8.2. Market Estimation and Penetration, 2015 - 2020
11.2.8.3. Market Forecast, 2021 - 2029
11.2.8.4. Compound Annual Growth Rate (CAGR)
11.2.8.5. Regional Bifurcation
11.2.8.5.1. North America
11.2.8.5.1.1. Market
Estimation, 2015 - 2020
11.2.8.5.1.2. Market
Forecast, 2021 - 2029
11.2.8.5.2. Europe
11.2.8.5.2.1. Market
Estimation, 2015 - 2020
11.2.8.5.2.2. Market
Forecast, 2021 - 2029
11.2.8.5.3. Asia Pacific
11.2.8.5.3.1. Market
Estimation, 2015 - 2020
11.2.8.5.3.2. Market
Forecast, 2021 - 2029
11.2.8.5.4. Middle East and Africa
11.2.8.5.4.1. Market
Estimation, 2015 - 2020
11.2.8.5.4.2. Market
Forecast, 2021 - 2029
11.2.8.5.5. Latin America
11.2.8.5.5.1. Market
Estimation, 2015 - 2020
11.2.8.5.5.2. Market
Forecast, 2021 - 2029
11.2.9. Others
11.2.9.1. Definition
11.2.9.2. Market Estimation and Penetration, 2015 - 2020
11.2.9.3. Market Forecast, 2021 - 2029
11.2.9.4. Compound Annual Growth Rate (CAGR)
11.2.9.5. Regional Bifurcation
11.2.9.5.1. North America
11.2.9.5.1.1. Market
Estimation, 2015 - 2020
11.2.9.5.1.2. Market
Forecast, 2021 - 2029
11.2.9.5.2. Europe
11.2.9.5.2.1. Market
Estimation, 2015 - 2020
11.2.9.5.2.2. Market
Forecast, 2021 - 2029
11.2.9.5.3. Asia Pacific
11.2.9.5.3.1. Market
Estimation, 2015 - 2020
11.2.9.5.3.2. Market
Forecast, 2021 - 2029
11.2.9.5.4. Middle East and Africa
11.2.9.5.4.1. Market
Estimation, 2015 - 2020
11.2.9.5.4.2. Market
Forecast, 2021 - 2029
11.2.9.5.5. Latin America
11.2.9.5.5.1. Market
Estimation, 2015 - 2020
11.2.9.5.5.2. Market
Forecast, 2021 - 2029
11.3. Key
Segment for Channeling Investments
11.3.1. By End
Users
12. North America Digital Pathology Market Analysis and
Forecasts, 2021 - 2029
12.1. Overview
12.1.1. North
America Digital Pathology Market Revenue (US$ Mn)
12.2. North
America Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Type
12.2.1. Human
12.2.2. Veterinary
12.3. North
America Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Offering
12.3.1. Software
12.3.1.1. Pathology Management System
12.3.1.2. Laboratory Information System
12.3.1.3. Others
12.3.2. Hardware
12.3.2.1. Diagnostic Scanners
12.3.2.2. Laboratory Components
12.3.2.3. Histology equipment
12.3.2.4. Others
12.3.3. Support
and Technical services
12.3.4. Others
12.4. North
America Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Application
12.4.1. Drug
Discovery
12.4.2. Disease
Diagnosis
12.4.3. Teleconsultation
12.4.4. Training
and Education
12.4.5. Others
12.5. North
America Digital Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Research
Institutions
12.5.2. Pathology
Laboratories
12.5.3. Pharmaceutical
and Biotechnology Companies
12.5.4. Contract
Research Organizations
12.5.5. Academic
Medical Centers (Education)
12.5.6. Clinical
Labs
12.5.7. Geology
12.5.8. Hospitals
12.5.9. Others
12.6. North
America Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Type
12.6.1.1.1. Human
12.6.1.1.2. Veterinary
12.6.1.2. U.S Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Offering
12.6.1.2.1. Software
12.6.1.2.1.1. Pathology
Management System
12.6.1.2.1.2. Laboratory
Information System
12.6.1.2.1.3. Others
12.6.1.2.2. Hardware
12.6.1.2.2.1. Diagnostic
Scanners
12.6.1.2.2.2. Laboratory
Components
12.6.1.2.2.3. Histology
equipment
12.6.1.2.2.4. Others
12.6.1.2.3. Support and Technical services
12.6.1.2.4. Others
12.6.1.3. U.S Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Application
12.6.1.3.1. Drug Discovery
12.6.1.3.2. Disease Diagnosis
12.6.1.3.3. Teleconsultation
12.6.1.3.4. Training and Education
12.6.1.3.5. Others
12.6.1.4. U.S Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
12.6.1.4.1. Research Institutions
12.6.1.4.2. Pathology Laboratories
12.6.1.4.3. Pharmaceutical and Biotechnology Companies
12.6.1.4.4. Contract Research Organizations
12.6.1.4.5. Academic Medical Centers (Education)
12.6.1.4.6. Clinical Labs
12.6.1.4.7. Geology
12.6.1.4.8. Hospitals
12.6.1.4.9. Others
12.6.2. Canada
12.6.2.1. Canada Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.2.1.1. Human
12.6.2.1.2. Veterinary
12.6.2.2. Canada Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
12.6.2.2.1. Software
12.6.2.2.1.1. Pathology
Management System
12.6.2.2.1.2. Laboratory
Information System
12.6.2.2.1.3. Others
12.6.2.2.2. Hardware
12.6.2.2.2.1. Diagnostic
Scanners
12.6.2.2.2.2. Laboratory
Components
12.6.2.2.2.3. Histology
equipment
12.6.2.2.2.4. Others
12.6.2.2.3. Support and Technical services
12.6.2.2.4. Others
12.6.2.3. Canada Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.2.3.1. Drug Discovery
12.6.2.3.2. Disease Diagnosis
12.6.2.3.3. Teleconsultation
12.6.2.3.4. Training and Education
12.6.2.3.5. Others
12.6.2.4. Canada Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
12.6.2.4.1. Research Institutions
12.6.2.4.2. Pathology Laboratories
12.6.2.4.3. Pharmaceutical and Biotechnology Companies
12.6.2.4.4. Contract Research Organizations
12.6.2.4.5. Academic Medical Centers (Education)
12.6.2.4.6. Clinical Labs
12.6.2.4.7. Geology
12.6.2.4.8. Hospitals
12.6.2.4.9. Others
12.6.3. Mexico
12.6.3.1. Mexico Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.3.1.1. Human
12.6.3.1.2. Veterinary
12.6.3.2. Mexico Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
12.6.3.2.1. Software
12.6.3.2.1.1. Pathology
Management System
12.6.3.2.1.2. Laboratory
Information System
12.6.3.2.1.3. Others
12.6.3.2.2. Hardware
12.6.3.2.2.1. Diagnostic
Scanners
12.6.3.2.2.2. Laboratory
Components
12.6.3.2.2.3. Histology
equipment
12.6.3.2.2.4. Others
12.6.3.2.3. Support and Technical services
12.6.3.2.4. Others
12.6.3.3. Mexico Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.3.3.1. Drug Discovery
12.6.3.3.2. Disease Diagnosis
12.6.3.3.3. Teleconsultation
12.6.3.3.4. Training and Education
12.6.3.3.5. Others
12.6.3.4. Mexico Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
12.6.3.4.1. Research Institutions
12.6.3.4.2. Pathology Laboratories
12.6.3.4.3. Pharmaceutical and Biotechnology Companies
12.6.3.4.4. Contract Research Organizations
12.6.3.4.5. Academic Medical Centers (Education)
12.6.3.4.6. Clinical Labs
12.6.3.4.7. Geology
12.6.3.4.8. Hospitals
12.6.3.4.9. Others
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Digital Pathology Market Revenue (US$
Mn) and Forecasts, By Type
12.6.4.1.1. Human
12.6.4.1.2. Veterinary
12.6.4.2. Rest of North America Digital Pathology Market Revenue (US$
Mn) and Forecasts, By Offering
12.6.4.2.1. Software
12.6.4.2.1.1. Pathology
Management System
12.6.4.2.1.2. Laboratory
Information System
12.6.4.2.1.3. Others
12.6.4.2.2. Hardware
12.6.4.2.2.1. Diagnostic
Scanners
12.6.4.2.2.2. Laboratory
Components
12.6.4.2.2.3. Histology
equipment
12.6.4.2.2.4. Others
12.6.4.2.3. Support and Technical services
12.6.4.2.4. Others
12.6.4.3. Rest of North America Digital Pathology Market Revenue (US$
Mn) and Forecasts, By Application
12.6.4.3.1. Drug Discovery
12.6.4.3.2. Disease Diagnosis
12.6.4.3.3. Teleconsultation
12.6.4.3.4. Training and Education
12.6.4.3.5. Others
12.6.4.4. Rest of North America Digital Pathology Market Revenue (US$
Mn) and Forecasts, By End Users
12.6.4.4.1. Research Institutions
12.6.4.4.2. Pathology Laboratories
12.6.4.4.3. Pharmaceutical and Biotechnology Companies
12.6.4.4.4. Contract Research Organizations
12.6.4.4.5. Academic Medical Centers (Education)
12.6.4.4.6. Clinical Labs
12.6.4.4.7. Geology
12.6.4.4.8. Hospitals
12.6.4.4.9. Others
12.7. Key Segment
for Channeling Investments
12.7.1. By
Country
12.7.2. By Type
12.7.3. By
Offering
12.7.4. By
Application
12.7.5. By End
Users
13. Europe Digital Pathology Market Analysis and Forecasts, 2021
- 2029
13.1. Overview
13.1.1. Europe
Digital Pathology Market Revenue (US$ Mn)
13.2. Europe
Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1. Human
13.2.2. Veterinary
13.3. Europe
Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Offering
13.3.1. Software
13.3.1.1. Pathology Management System
13.3.1.2. Laboratory Information System
13.3.1.3. Others
13.3.2. Hardware
13.3.2.1. Diagnostic Scanners
13.3.2.2. Laboratory Components
13.3.2.3. Histology equipment
13.3.2.4. Others
13.3.3. Support
and Technical services
13.3.4. Others
13.4. Europe
Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1. Drug
Discovery
13.4.2. Disease
Diagnosis
13.4.3. Teleconsultation
13.4.4. Training
and Education
13.4.5. Others
13.5. Europe
Digital Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Research
Institutions
13.5.2. Pathology
Laboratories
13.5.3. Pharmaceutical
and Biotechnology Companies
13.5.4. Contract
Research Organizations
13.5.5. Academic
Medical Centers (Education)
13.5.6. Clinical
Labs
13.5.7. Geology
13.5.8. Hospitals
13.5.9. Others
13.6. Europe
Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.1.1.1. Human
13.6.1.1.2. Veterinary
13.6.1.2. France Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.1.2.1. Software
13.6.1.2.1.1. Pathology
Management System
13.6.1.2.1.2. Laboratory
Information System
13.6.1.2.1.3. Others
13.6.1.2.2. Hardware
13.6.1.2.2.1. Diagnostic
Scanners
13.6.1.2.2.2. Laboratory
Components
13.6.1.2.2.3. Histology
equipment
13.6.1.2.2.4. Others
13.6.1.2.3. Support and Technical services
13.6.1.2.4. Others
13.6.1.3. France Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.1.3.1. Drug Discovery
13.6.1.3.2. Disease Diagnosis
13.6.1.3.3. Teleconsultation
13.6.1.3.4. Training and Education
13.6.1.3.5. Others
13.6.1.4. France Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.1.4.1. Research Institutions
13.6.1.4.2. Pathology Laboratories
13.6.1.4.3. Pharmaceutical and Biotechnology Companies
13.6.1.4.4. Contract Research Organizations
13.6.1.4.5. Academic Medical Centers (Education)
13.6.1.4.6. Clinical Labs
13.6.1.4.7. Geology
13.6.1.4.8. Hospitals
13.6.1.4.9. Others
13.6.2. The UK
13.6.2.1. The UK Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.2.1.1. Human
13.6.2.1.2. Veterinary
13.6.2.2. The UK Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.2.2.1. Software
13.6.2.2.1.1. Pathology
Management System
13.6.2.2.1.2. Laboratory
Information System
13.6.2.2.1.3. Others
13.6.2.2.2. Hardware
13.6.2.2.2.1. Diagnostic
Scanners
13.6.2.2.2.2. Laboratory
Components
13.6.2.2.2.3. Histology
equipment
13.6.2.2.2.4. Others
13.6.2.2.3. Support and Technical services
13.6.2.2.4. Others
13.6.2.3. The UK Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.2.3.1. Drug Discovery
13.6.2.3.2. Disease Diagnosis
13.6.2.3.3. Teleconsultation
13.6.2.3.4. Training and Education
13.6.2.3.5. Others
13.6.2.4. The UK Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.2.4.1. Research Institutions
13.6.2.4.2. Pathology Laboratories
13.6.2.4.3. Pharmaceutical and Biotechnology Companies
13.6.2.4.4. Contract Research Organizations
13.6.2.4.5. Academic Medical Centers (Education)
13.6.2.4.6. Clinical Labs
13.6.2.4.7. Geology
13.6.2.4.8. Hospitals
13.6.2.4.9. Others
13.6.3. Spain
13.6.3.1. Spain Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.3.1.1. Human
13.6.3.1.2. Veterinary
13.6.3.2. Spain Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.3.2.1. Software
13.6.3.2.1.1. Pathology
Management System
13.6.3.2.1.2. Laboratory
Information System
13.6.3.2.1.3. Others
13.6.3.2.2. Hardware
13.6.3.2.2.1. Diagnostic
Scanners
13.6.3.2.2.2. Laboratory
Components
13.6.3.2.2.3. Histology
equipment
13.6.3.2.2.4. Others
13.6.3.2.3. Support and Technical services
13.6.3.2.4. Others
13.6.3.3. Spain Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.3.3.1. Drug Discovery
13.6.3.3.2. Disease Diagnosis
13.6.3.3.3. Teleconsultation
13.6.3.3.4. Training and Education
13.6.3.3.5. Others
13.6.3.4. Spain Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.3.4.1. Research Institutions
13.6.3.4.2. Pathology Laboratories
13.6.3.4.3. Pharmaceutical and Biotechnology Companies
13.6.3.4.4. Contract Research Organizations
13.6.3.4.5. Academic Medical Centers (Education)
13.6.3.4.6. Clinical Labs
13.6.3.4.7. Geology
13.6.3.4.8. Hospitals
13.6.3.4.9. Others
13.6.4. Germany
13.6.4.1. Germany Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.4.1.1. Human
13.6.4.1.2. Veterinary
13.6.4.2. Germany Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.4.2.1. Software
13.6.4.2.1.1. Pathology
Management System
13.6.4.2.1.2. Laboratory
Information System
13.6.4.2.1.3. Others
13.6.4.2.2. Hardware
13.6.4.2.2.1. Diagnostic
Scanners
13.6.4.2.2.2. Laboratory
Components
13.6.4.2.2.3. Histology
equipment
13.6.4.2.2.4. Others
13.6.4.2.3. Support and Technical services
13.6.4.2.4. Others
13.6.4.3. Germany Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.4.3.1. Drug Discovery
13.6.4.3.2. Disease Diagnosis
13.6.4.3.3. Teleconsultation
13.6.4.3.4. Training and Education
13.6.4.3.5. Others
13.6.4.4. Germany Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.4.4.1. Research Institutions
13.6.4.4.2. Pathology Laboratories
13.6.4.4.3. Pharmaceutical and Biotechnology Companies
13.6.4.4.4. Contract Research Organizations
13.6.4.4.5. Academic Medical Centers (Education)
13.6.4.4.6. Clinical Labs
13.6.4.4.7. Geology
13.6.4.4.8. Hospitals
13.6.4.4.9. Others
13.6.5. Italy
13.6.5.1. Italy Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.5.1.1. Human
13.6.5.1.2. Veterinary
13.6.5.2. Italy Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.5.2.1. Software
13.6.5.2.1.1. Pathology
Management System
13.6.5.2.1.2. Laboratory
Information System
13.6.5.2.1.3. Others
13.6.5.2.2. Hardware
13.6.5.2.2.1. Diagnostic
Scanners
13.6.5.2.2.2. Laboratory
Components
13.6.5.2.2.3. Histology
equipment
13.6.5.2.2.4. Others
13.6.5.2.3. Support and Technical services
13.6.5.2.4. Others
13.6.5.3. Italy Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.5.3.1. Drug Discovery
13.6.5.3.2. Disease Diagnosis
13.6.5.3.3. Teleconsultation
13.6.5.3.4. Training and Education
13.6.5.3.5. Others
13.6.5.4. Italy Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.5.4.1. Research Institutions
13.6.5.4.2. Pathology Laboratories
13.6.5.4.3. Pharmaceutical and Biotechnology Companies
13.6.5.4.4. Contract Research Organizations
13.6.5.4.5. Academic Medical Centers (Education)
13.6.5.4.6. Clinical Labs
13.6.5.4.7. Geology
13.6.5.4.8. Hospitals
13.6.5.4.9. Others
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.6.1.1. Human
13.6.6.1.2. Veterinary
13.6.6.2. Nordic Countries Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.6.2.1. Software
13.6.6.2.1.1. Pathology
Management System
13.6.6.2.1.2. Laboratory
Information System
13.6.6.2.1.3. Others
13.6.6.2.2. Hardware
13.6.6.2.2.1. Diagnostic
Scanners
13.6.6.2.2.2. Laboratory
Components
13.6.6.2.2.3. Histology
equipment
13.6.6.2.2.4. Others
13.6.6.2.3. Support and Technical services
13.6.6.2.4. Others
13.6.6.3. Nordic Countries Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.6.3.1. Drug Discovery
13.6.6.3.2. Disease Diagnosis
13.6.6.3.3. Teleconsultation
13.6.6.3.4. Training and Education
13.6.6.3.5. Others
13.6.6.4. Nordic Countries Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.6.4.1. Research Institutions
13.6.6.4.2. Pathology Laboratories
13.6.6.4.3. Pharmaceutical and Biotechnology Companies
13.6.6.4.4. Contract Research Organizations
13.6.6.4.5. Academic Medical Centers (Education)
13.6.6.4.6. Clinical Labs
13.6.6.4.7. Geology
13.6.6.4.8. Hospitals
13.6.6.4.9. Others
13.6.6.5. Nordic Countries Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.7.1.1. Human
13.6.7.1.2. Veterinary
13.6.7.2. Benelux Union Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.7.2.1. Software
13.6.7.2.1.1. Pathology
Management System
13.6.7.2.1.2. Laboratory
Information System
13.6.7.2.1.3. Others
13.6.7.2.2. Hardware
13.6.7.2.2.1. Diagnostic
Scanners
13.6.7.2.2.2. Laboratory
Components
13.6.7.2.2.3. Histology
equipment
13.6.7.2.2.4. Others
13.6.7.2.3. Support and Technical services
13.6.7.2.4. Others
13.6.7.3. Benelux Union Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.7.3.1. Drug Discovery
13.6.7.3.2. Disease Diagnosis
13.6.7.3.3. Teleconsultation
13.6.7.3.4. Training and Education
13.6.7.3.5. Others
13.6.7.4. Benelux Union Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.7.4.1. Research Institutions
13.6.7.4.2. Pathology Laboratories
13.6.7.4.3. Pharmaceutical and Biotechnology Companies
13.6.7.4.4. Contract Research Organizations
13.6.7.4.5. Academic Medical Centers (Education)
13.6.7.4.6. Clinical Labs
13.6.7.4.7. Geology
13.6.7.4.8. Hospitals
13.6.7.4.9. Others
13.6.7.5. Benelux Union Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.8.1.1. Human
13.6.8.1.2. Veterinary
13.6.8.2. Rest of Europe Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.8.2.1. Software
13.6.8.2.1.1. Pathology
Management System
13.6.8.2.1.2. Laboratory
Information System
13.6.8.2.1.3. Others
13.6.8.2.2. Hardware
13.6.8.2.2.1. Diagnostic
Scanners
13.6.8.2.2.2. Laboratory
Components
13.6.8.2.2.3. Histology
equipment
13.6.8.2.2.4. Others
13.6.8.2.3. Support and Technical services
13.6.8.2.4. Others
13.6.8.3. Rest of Europe Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.8.3.1. Drug Discovery
13.6.8.3.2. Disease Diagnosis
13.6.8.3.3. Teleconsultation
13.6.8.3.4. Training and Education
13.6.8.3.5. Others
13.6.8.4. Rest of Europe Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.8.4.1. Research Institutions
13.6.8.4.2. Pathology Laboratories
13.6.8.4.3. Pharmaceutical and Biotechnology Companies
13.6.8.4.4. Contract Research Organizations
13.6.8.4.5. Academic Medical Centers (Education)
13.6.8.4.6. Clinical Labs
13.6.8.4.7. Geology
13.6.8.4.8. Hospitals
13.6.8.4.9. Others
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By Type
13.7.3. By
Offering
13.7.4. By
Application
13.7.5. By End
Users
14. Asia Pacific Digital Pathology Market Analysis and Forecasts,
2021 - 2029
14.1. Overview
14.1.1. Asia
Pacific Digital Pathology Market Revenue (US$ Mn)
14.2. Asia
Pacific Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Human
14.2.2. Veterinary
14.3. Asia
Pacific Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Offering
14.3.1. Software
14.3.1.1. Pathology Management System
14.3.1.2. Laboratory Information System
14.3.1.3. Others
14.3.2. Hardware
14.3.2.1. Diagnostic Scanners
14.3.2.2. Laboratory Components
14.3.2.3. Histology equipment
14.3.2.4. Others
14.3.3. Support
and Technical services
14.3.4. Others
14.4. Asia
Pacific Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1. Drug
Discovery
14.4.2. Disease
Diagnosis
14.4.3. Teleconsultation
14.4.4. Training
and Education
14.4.5. Others
14.5. Asia
Pacific Digital Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Research
Institutions
14.5.2. Pathology
Laboratories
14.5.3. Pharmaceutical
and Biotechnology Companies
14.5.4. Contract
Research Organizations
14.5.5. Academic
Medical Centers (Education)
14.5.6. Clinical
Labs
14.5.7. Geology
14.5.8. Hospitals
14.5.9. Others
14.6. Asia
Pacific Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Type
14.6.1.1.1. Human
14.6.1.1.2. Veterinary
14.6.1.2. China Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Offering
14.6.1.2.1. Software
14.6.1.2.1.1. Pathology
Management System
14.6.1.2.1.2. Laboratory
Information System
14.6.1.2.1.3. Others
14.6.1.2.2. Hardware
14.6.1.2.2.1. Diagnostic
Scanners
14.6.1.2.2.2. Laboratory
Components
14.6.1.2.2.3. Histology
equipment
14.6.1.2.2.4. Others
14.6.1.2.3. Support and Technical services
14.6.1.2.4. Others
14.6.1.3. China Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Application
14.6.1.3.1. Drug Discovery
14.6.1.3.2. Disease Diagnosis
14.6.1.3.3. Teleconsultation
14.6.1.3.4. Training and Education
14.6.1.3.5. Others
14.6.1.4. China Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.1.4.1. Research Institutions
14.6.1.4.2. Pathology Laboratories
14.6.1.4.3. Pharmaceutical and Biotechnology Companies
14.6.1.4.4. Contract Research Organizations
14.6.1.4.5. Academic Medical Centers (Education)
14.6.1.4.6. Clinical Labs
14.6.1.4.7. Geology
14.6.1.4.8. Hospitals
14.6.1.4.9. Others
14.6.2. Japan
14.6.2.1. Japan Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Type
14.6.2.1.1. Human
14.6.2.1.2. Veterinary
14.6.2.2. Japan Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Offering
14.6.2.2.1. Software
14.6.2.2.1.1. Pathology
Management System
14.6.2.2.1.2. Laboratory
Information System
14.6.2.2.1.3. Others
14.6.2.2.2. Hardware
14.6.2.2.2.1. Diagnostic
Scanners
14.6.2.2.2.2. Laboratory
Components
14.6.2.2.2.3. Histology
equipment
14.6.2.2.2.4. Others
14.6.2.2.3. Support and Technical services
14.6.2.2.4. Others
14.6.2.3. Japan Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Application
14.6.2.3.1. Drug Discovery
14.6.2.3.2. Disease Diagnosis
14.6.2.3.3. Teleconsultation
14.6.2.3.4. Training and Education
14.6.2.3.5. Others
14.6.2.4. Japan Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.2.4.1. Research Institutions
14.6.2.4.2. Pathology Laboratories
14.6.2.4.3. Pharmaceutical and Biotechnology Companies
14.6.2.4.4. Contract Research Organizations
14.6.2.4.5. Academic Medical Centers (Education)
14.6.2.4.6. Clinical Labs
14.6.2.4.7. Geology
14.6.2.4.8. Hospitals
14.6.2.4.9. Others
14.6.3. India
14.6.3.1. India Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Type
14.6.3.1.1. Human
14.6.3.1.2. Veterinary
14.6.3.2. India Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Offering
14.6.3.2.1. Software
14.6.3.2.1.1. Pathology
Management System
14.6.3.2.1.2. Laboratory
Information System
14.6.3.2.1.3. Others
14.6.3.2.2. Hardware
14.6.3.2.2.1. Diagnostic
Scanners
14.6.3.2.2.2. Laboratory
Components
14.6.3.2.2.3. Histology
equipment
14.6.3.2.2.4. Others
14.6.3.2.3. Support and Technical services
14.6.3.2.4. Others
14.6.3.3. India Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Application
14.6.3.3.1. Drug Discovery
14.6.3.3.2. Disease Diagnosis
14.6.3.3.3. Teleconsultation
14.6.3.3.4. Training and Education
14.6.3.3.5. Others
14.6.3.4. India Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.3.4.1. Research Institutions
14.6.3.4.2. Pathology Laboratories
14.6.3.4.3. Pharmaceutical and Biotechnology Companies
14.6.3.4.4. Contract Research Organizations
14.6.3.4.5. Academic Medical Centers (Education)
14.6.3.4.6. Clinical Labs
14.6.3.4.7. Geology
14.6.3.4.8. Hospitals
14.6.3.4.9. Others
14.6.4. New
Zealand
14.6.4.1. New Zealand Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.4.1.1. Human
14.6.4.1.2. Veterinary
14.6.4.2. New Zealand Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.4.2.1. Software
14.6.4.2.1.1. Pathology
Management System
14.6.4.2.1.2. Laboratory
Information System
14.6.4.2.1.3. Others
14.6.4.2.2. Hardware
14.6.4.2.2.1. Diagnostic
Scanners
14.6.4.2.2.2. Laboratory
Components
14.6.4.2.2.3. Histology
equipment
14.6.4.2.2.4. Others
14.6.4.2.3. Support and Technical services
14.6.4.2.4. Others
14.6.4.3. New Zealand Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.4.3.1. Drug Discovery
14.6.4.3.2. Disease Diagnosis
14.6.4.3.3. Teleconsultation
14.6.4.3.4. Training and Education
14.6.4.3.5. Others
14.6.4.4. New Zealand Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.4.4.1. Research Institutions
14.6.4.4.2. Pathology Laboratories
14.6.4.4.3. Pharmaceutical and Biotechnology Companies
14.6.4.4.4. Contract Research Organizations
14.6.4.4.5. Academic Medical Centers (Education)
14.6.4.4.6. Clinical Labs
14.6.4.4.7. Geology
14.6.4.4.8. Hospitals
14.6.4.4.9. Others
14.6.5. Australia
14.6.5.1. Australia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.5.1.1. Human
14.6.5.1.2. Veterinary
14.6.5.2. Australia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.5.2.1. Software
14.6.5.2.1.1. Pathology
Management System
14.6.5.2.1.2. Laboratory
Information System
14.6.5.2.1.3. Others
14.6.5.2.2. Hardware
14.6.5.2.2.1. Diagnostic
Scanners
14.6.5.2.2.2. Laboratory
Components
14.6.5.2.2.3. Histology
equipment
14.6.5.2.2.4. Others
14.6.5.2.3. Support and Technical services
14.6.5.2.4. Others
14.6.5.3. Australia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.5.3.1. Drug Discovery
14.6.5.3.2. Disease Diagnosis
14.6.5.3.3. Teleconsultation
14.6.5.3.4. Training and Education
14.6.5.3.5. Others
14.6.5.4. Australia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.5.4.1. Research Institutions
14.6.5.4.2. Pathology Laboratories
14.6.5.4.3. Pharmaceutical and Biotechnology Companies
14.6.5.4.4. Contract Research Organizations
14.6.5.4.5. Academic Medical Centers (Education)
14.6.5.4.6. Clinical Labs
14.6.5.4.7. Geology
14.6.5.4.8. Hospitals
14.6.5.4.9. Others
14.6.6. South
Korea
14.6.6.1. South Korea Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.6.1.1. Human
14.6.6.1.2. Veterinary
14.6.6.2. South Korea Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.6.2.1. Software
14.6.6.2.1.1. Pathology
Management System
14.6.6.2.1.2. Laboratory
Information System
14.6.6.2.1.3. Others
14.6.6.2.2. Hardware
14.6.6.2.2.1. Diagnostic
Scanners
14.6.6.2.2.2. Laboratory
Components
14.6.6.2.2.3. Histology
equipment
14.6.6.2.2.4. Others
14.6.6.2.3. Support and Technical services
14.6.6.2.4. Others
14.6.6.3. South Korea Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.6.3.1. Drug Discovery
14.6.6.3.2. Disease Diagnosis
14.6.6.3.3. Teleconsultation
14.6.6.3.4. Training and Education
14.6.6.3.5. Others
14.6.6.4. South Korea Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.6.4.1. Research Institutions
14.6.6.4.2. Pathology Laboratories
14.6.6.4.3. Pharmaceutical and Biotechnology Companies
14.6.6.4.4. Contract Research Organizations
14.6.6.4.5. Academic Medical Centers (Education)
14.6.6.4.6. Clinical Labs
14.6.6.4.7. Geology
14.6.6.4.8. Hospitals
14.6.6.4.9. Others
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.7.1.1. Human
14.6.7.1.2. Veterinary
14.6.7.2. Southeast Asia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.7.2.1. Software
14.6.7.2.1.1. Pathology
Management System
14.6.7.2.1.2. Laboratory
Information System
14.6.7.2.1.3. Others
14.6.7.2.2. Hardware
14.6.7.2.2.1. Diagnostic
Scanners
14.6.7.2.2.2. Laboratory
Components
14.6.7.2.2.3. Histology
equipment
14.6.7.2.2.4. Others
14.6.7.2.3. Support and Technical services
14.6.7.2.4. Others
14.6.7.3. Southeast Asia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.7.3.1. Drug Discovery
14.6.7.3.2. Disease Diagnosis
14.6.7.3.3. Teleconsultation
14.6.7.3.4. Training and Education
14.6.7.3.5. Others
14.6.7.4. Southeast Asia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.7.4.1. Research Institutions
14.6.7.4.2. Pathology Laboratories
14.6.7.4.3. Pharmaceutical and Biotechnology Companies
14.6.7.4.4. Contract Research Organizations
14.6.7.4.5. Academic Medical Centers (Education)
14.6.7.4.6. Clinical Labs
14.6.7.4.7. Geology
14.6.7.4.8. Hospitals
14.6.7.4.9. Others
14.6.7.5. Southeast Asia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Digital Pathology Market Revenue (US$ Mn)
and Forecasts, By Type
14.6.8.1.1. Human
14.6.8.1.2. Veterinary
14.6.8.2. Rest of Asia Pacific Digital Pathology Market Revenue (US$ Mn)
and Forecasts, By Offering
14.6.8.2.1. Software
14.6.8.2.1.1. Pathology
Management System
14.6.8.2.1.2. Laboratory
Information System
14.6.8.2.1.3. Others
14.6.8.2.2. Hardware
14.6.8.2.2.1. Diagnostic
Scanners
14.6.8.2.2.2. Laboratory
Components
14.6.8.2.2.3. Histology
equipment
14.6.8.2.2.4. Others
14.6.8.2.3. Support and Technical services
14.6.8.2.4. Others
14.6.8.3. Rest of Asia Pacific Digital Pathology Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.8.3.1. Drug Discovery
14.6.8.3.2. Disease Diagnosis
14.6.8.3.3. Teleconsultation
14.6.8.3.4. Training and Education
14.6.8.3.5. Others
14.6.8.4. Rest of Asia Pacific Digital Pathology Market Revenue (US$ Mn)
and Forecasts, By End Users
14.6.8.4.1. Research Institutions
14.6.8.4.2. Pathology Laboratories
14.6.8.4.3. Pharmaceutical and Biotechnology Companies
14.6.8.4.4. Contract Research Organizations
14.6.8.4.5. Academic Medical Centers (Education)
14.6.8.4.6. Clinical Labs
14.6.8.4.7. Geology
14.6.8.4.8. Hospitals
14.6.8.4.9. Others
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By Type
14.7.3. By
Offering
14.7.4. By
Application
14.7.5. By End
Users
15. Middle East and Africa Digital Pathology Market Analysis and
Forecasts, 2021 - 2029
15.1. Overview
15.1.1. Middle
East and Africa Digital Pathology Market Revenue (US$ Mn)
15.2. Middle
East and Africa Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Type
15.2.1. Human
15.2.2. Veterinary
15.3. Middle
East and Africa Digital Pathology Market Revenue (US$ Mn) and Forecasts, By
Offering
15.3.1. Software
15.3.1.1. Pathology Management System
15.3.1.2. Laboratory Information System
15.3.1.3. Others
15.3.2. Hardware
15.3.2.1. Diagnostic Scanners
15.3.2.2. Laboratory Components
15.3.2.3. Histology equipment
15.3.2.4. Others
15.3.3. Support
and Technical services
15.3.4. Others
15.4. Middle
East and Africa Digital Pathology Market Revenue (US$ Mn) and Forecasts, By
Application
15.4.1. Drug
Discovery
15.4.2. Disease
Diagnosis
15.4.3. Teleconsultation
15.4.4. Training
and Education
15.4.5. Others
15.5. Middle
East and Africa Digital Pathology Market Revenue (US$ Mn) and Forecasts, By End
Users
15.5.1. Research
Institutions
15.5.2. Pathology
Laboratories
15.5.3. Pharmaceutical
and Biotechnology Companies
15.5.4. Contract
Research Organizations
15.5.5. Academic
Medical Centers (Education)
15.5.6. Clinical
Labs
15.5.7. Geology
15.5.8. Hospitals
15.5.9. Others
15.6. Middle
East and Africa Digital Pathology Market Revenue (US$ Mn) and Forecasts, By
Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.1.1.1. Human
15.6.1.1.2. Veterinary
15.6.1.2. Saudi Arabia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.1.2.1. Software
15.6.1.2.1.1. Pathology
Management System
15.6.1.2.1.2. Laboratory
Information System
15.6.1.2.1.3. Others
15.6.1.2.2. Hardware
15.6.1.2.2.1. Diagnostic
Scanners
15.6.1.2.2.2. Laboratory
Components
15.6.1.2.2.3. Histology
equipment
15.6.1.2.2.4. Others
15.6.1.2.3. Support and Technical services
15.6.1.2.4. Others
15.6.1.3. Saudi Arabia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.1.3.1. Drug Discovery
15.6.1.3.2. Disease Diagnosis
15.6.1.3.3. Teleconsultation
15.6.1.3.4. Training and Education
15.6.1.3.5. Others
15.6.1.4. Saudi Arabia Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.1.4.1. Research Institutions
15.6.1.4.2. Pathology Laboratories
15.6.1.4.3. Pharmaceutical and Biotechnology Companies
15.6.1.4.4. Contract Research Organizations
15.6.1.4.5. Academic Medical Centers (Education)
15.6.1.4.6. Clinical Labs
15.6.1.4.7. Geology
15.6.1.4.8. Hospitals
15.6.1.4.9. Others
15.6.2. UAE
15.6.2.1. UAE Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Type
15.6.2.1.1. Human
15.6.2.1.2. Veterinary
15.6.2.2. UAE Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Offering
15.6.2.2.1. Software
15.6.2.2.1.1. Pathology
Management System
15.6.2.2.1.2. Laboratory
Information System
15.6.2.2.1.3. Others
15.6.2.2.2. Hardware
15.6.2.2.2.1. Diagnostic
Scanners
15.6.2.2.2.2. Laboratory
Components
15.6.2.2.2.3. Histology
equipment
15.6.2.2.2.4. Others
15.6.2.2.3. Support and Technical services
15.6.2.2.4. Others
15.6.2.3. UAE Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Application
15.6.2.3.1. Drug Discovery
15.6.2.3.2. Disease Diagnosis
15.6.2.3.3. Teleconsultation
15.6.2.3.4. Training and Education
15.6.2.3.5. Others
15.6.2.4. UAE Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.2.4.1. Research Institutions
15.6.2.4.2. Pathology Laboratories
15.6.2.4.3. Pharmaceutical and Biotechnology Companies
15.6.2.4.4. Contract Research Organizations
15.6.2.4.5. Academic Medical Centers (Education)
15.6.2.4.6. Clinical Labs
15.6.2.4.7. Geology
15.6.2.4.8. Hospitals
15.6.2.4.9. Others
15.6.3. Egypt
15.6.3.1. Egypt Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Type
15.6.3.1.1. Human
15.6.3.1.2. Veterinary
15.6.3.2. Egypt Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Offering
15.6.3.2.1. Software
15.6.3.2.1.1. Pathology
Management System
15.6.3.2.1.2. Laboratory
Information System
15.6.3.2.1.3. Others
15.6.3.2.2. Hardware
15.6.3.2.2.1. Diagnostic
Scanners
15.6.3.2.2.2. Laboratory
Components
15.6.3.2.2.3. Histology
equipment
15.6.3.2.2.4. Others
15.6.3.2.3. Support and Technical services
15.6.3.2.4. Others
15.6.3.3. Egypt Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Application
15.6.3.3.1. Drug Discovery
15.6.3.3.2. Disease Diagnosis
15.6.3.3.3. Teleconsultation
15.6.3.3.4. Training and Education
15.6.3.3.5. Others
15.6.3.4. Egypt Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.3.4.1. Research Institutions
15.6.3.4.2. Pathology Laboratories
15.6.3.4.3. Pharmaceutical and Biotechnology Companies
15.6.3.4.4. Contract Research Organizations
15.6.3.4.5. Academic Medical Centers (Education)
15.6.3.4.6. Clinical Labs
15.6.3.4.7. Geology
15.6.3.4.8. Hospitals
15.6.3.4.9. Others
15.6.4. Kuwait
15.6.4.1. Kuwait Digital Pathology Market Revenue (US$ Mn) and Forecasts,
By Type
15.6.4.1.1. Human
15.6.4.1.2. Veterinary
15.6.4.2. Kuwait Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.4.2.1. Software
15.6.4.2.1.1. Pathology
Management System
15.6.4.2.1.2. Laboratory
Information System
15.6.4.2.1.3. Others
15.6.4.2.2. Hardware
15.6.4.2.2.1. Diagnostic
Scanners
15.6.4.2.2.2. Laboratory
Components
15.6.4.2.2.3. Histology
equipment
15.6.4.2.2.4. Others
15.6.4.2.3. Support and Technical services
15.6.4.2.4. Others
15.6.4.3. Kuwait Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.4.3.1. Drug Discovery
15.6.4.3.2. Disease Diagnosis
15.6.4.3.3. Teleconsultation
15.6.4.3.4. Training and Education
15.6.4.3.5. Others
15.6.4.4. Kuwait Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.4.4.1. Research Institutions
15.6.4.4.2. Pathology Laboratories
15.6.4.4.3. Pharmaceutical and Biotechnology Companies
15.6.4.4.4. Contract Research Organizations
15.6.4.4.5. Academic Medical Centers (Education)
15.6.4.4.6. Clinical Labs
15.6.4.4.7. Geology
15.6.4.4.8. Hospitals
15.6.4.4.9. Others
15.6.5. South
Africa
15.6.5.1. South Africa Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.5.1.1. Human
15.6.5.1.2. Veterinary
15.6.5.2. South Africa Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.5.2.1. Software
15.6.5.2.1.1. Pathology
Management System
15.6.5.2.1.2. Laboratory
Information System
15.6.5.2.1.3. Others
15.6.5.2.2. Hardware
15.6.5.2.2.1. Diagnostic
Scanners
15.6.5.2.2.2. Laboratory
Components
15.6.5.2.2.3. Histology
equipment
15.6.5.2.2.4. Others
15.6.5.2.3. Support and Technical services
15.6.5.2.4. Others
15.6.5.3. South Africa Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.5.3.1. Drug Discovery
15.6.5.3.2. Disease Diagnosis
15.6.5.3.3. Teleconsultation
15.6.5.3.4. Training and Education
15.6.5.3.5. Others
15.6.5.4. South Africa Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.5.4.1. Research Institutions
15.6.5.4.2. Pathology Laboratories
15.6.5.4.3. Pharmaceutical and Biotechnology Companies
15.6.5.4.4. Contract Research Organizations
15.6.5.4.5. Academic Medical Centers (Education)
15.6.5.4.6. Clinical Labs
15.6.5.4.7. Geology
15.6.5.4.8. Hospitals
15.6.5.4.9. Others
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Digital Pathology Market
Revenue (US$ Mn) and Forecasts, By Type
15.6.6.1.1. Human
15.6.6.1.2. Veterinary
15.6.6.2. Rest of Middle East & Africa Digital Pathology Market
Revenue (US$ Mn) and Forecasts, By Offering
15.6.6.2.1. Software
15.6.6.2.1.1. Pathology
Management System
15.6.6.2.1.2. Laboratory
Information System
15.6.6.2.1.3. Others
15.6.6.2.2. Hardware
15.6.6.2.2.1. Diagnostic
Scanners
15.6.6.2.2.2. Laboratory
Components
15.6.6.2.2.3. Histology
equipment
15.6.6.2.2.4. Others
15.6.6.2.3. Support and Technical services
15.6.6.2.4. Others
15.6.6.3. Rest of Middle East & Africa Digital Pathology Market
Revenue (US$ Mn) and Forecasts, By Application
15.6.6.3.1. Drug Discovery
15.6.6.3.2. Disease Diagnosis
15.6.6.3.3. Teleconsultation
15.6.6.3.4. Training and Education
15.6.6.3.5. Others
15.6.6.4. Rest of Middle East & Africa Digital Pathology Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Research Institutions
15.6.6.4.2. Pathology Laboratories
15.6.6.4.3. Pharmaceutical and Biotechnology Companies
15.6.6.4.4. Contract Research Organizations
15.6.6.4.5. Academic Medical Centers (Education)
15.6.6.4.6. Clinical Labs
15.6.6.4.7. Geology
15.6.6.4.8. Hospitals
15.6.6.4.9. Others
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By Type
15.7.3. By
Offering
15.7.4. By
Application
15.7.5. By End
Users
16. Latin America Digital Pathology Market Analysis and
Forecasts, 2021 - 2029
16.1. Overview
16.1.1. Latin
America Digital Pathology Market Revenue (US$ Mn)
16.2. Latin
America Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Type
16.2.1. Human
16.2.2. Veterinary
16.3. Latin
America Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Offering
16.3.1. Software
16.3.1.1. Pathology Management System
16.3.1.2. Laboratory Information System
16.3.1.3. Others
16.3.2. Hardware
16.3.2.1. Diagnostic Scanners
16.3.2.2. Laboratory Components
16.3.2.3. Histology equipment
16.3.2.4. Others
16.3.3. Support
and Technical services
16.3.4. Others
16.4. Latin
America Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Application
16.4.1. Drug
Discovery
16.4.2. Disease
Diagnosis
16.4.3. Teleconsultation
16.4.4. Training
and Education
16.4.5. Others
16.5. Latin
America Digital Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Research
Institutions
16.5.2. Pathology
Laboratories
16.5.3. Pharmaceutical
and Biotechnology Companies
16.5.4. Contract
Research Organizations
16.5.5. Academic
Medical Centers (Education)
16.5.6. Clinical
Labs
16.5.7. Geology
16.5.8. Hospitals
16.5.9. Others
16.6. Latin
America Digital Pathology Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
16.6.1.1.1. Human
16.6.1.1.2. Veterinary
16.6.1.2. Brazil Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
16.6.1.2.1. Software
16.6.1.2.1.1. Pathology
Management System
16.6.1.2.1.2. Laboratory
Information System
16.6.1.2.1.3. Others
16.6.1.2.2. Hardware
16.6.1.2.2.1. Diagnostic
Scanners
16.6.1.2.2.2. Laboratory
Components
16.6.1.2.2.3. Histology
equipment
16.6.1.2.2.4. Others
16.6.1.2.3. Support and Technical services
16.6.1.2.4. Others
16.6.1.3. Brazil Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.1.3.1. Drug Discovery
16.6.1.3.2. Disease Diagnosis
16.6.1.3.3. Teleconsultation
16.6.1.3.4. Training and Education
16.6.1.3.5. Others
16.6.1.4. Brazil Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
16.6.1.4.1. Research Institutions
16.6.1.4.2. Pathology Laboratories
16.6.1.4.3. Pharmaceutical and Biotechnology Companies
16.6.1.4.4. Contract Research Organizations
16.6.1.4.5. Academic Medical Centers (Education)
16.6.1.4.6. Clinical Labs
16.6.1.4.7. Geology
16.6.1.4.8. Hospitals
16.6.1.4.9. Others
16.6.2. Argentina
16.6.2.1. Argentina Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Type
16.6.2.1.1. Human
16.6.2.1.2. Veterinary
16.6.2.2. Argentina Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Offering
16.6.2.2.1. Software
16.6.2.2.1.1. Pathology
Management System
16.6.2.2.1.2. Laboratory
Information System
16.6.2.2.1.3. Others
16.6.2.2.2. Hardware
16.6.2.2.2.1. Diagnostic
Scanners
16.6.2.2.2.2. Laboratory
Components
16.6.2.2.2.3. Histology
equipment
16.6.2.2.2.4. Others
16.6.2.2.3. Support and Technical services
16.6.2.2.4. Others
16.6.2.3. Argentina Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.2.3.1. Drug Discovery
16.6.2.3.2. Disease Diagnosis
16.6.2.3.3. Teleconsultation
16.6.2.3.4. Training and Education
16.6.2.3.5. Others
16.6.2.4. Argentina Digital Pathology Market Revenue (US$ Mn) and
Forecasts, By End Users
16.6.2.4.1. Research Institutions
16.6.2.4.2. Pathology Laboratories
16.6.2.4.3. Pharmaceutical and Biotechnology Companies
16.6.2.4.4. Contract Research Organizations
16.6.2.4.5. Academic Medical Centers (Education)
16.6.2.4.6. Clinical Labs
16.6.2.4.7. Geology
16.6.2.4.8. Hospitals
16.6.2.4.9. Others
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Digital Pathology Market Revenue (US$
Mn) and Forecasts, By Type
16.6.3.1.1. Human
16.6.3.1.2. Veterinary
16.6.3.2. Rest of Latin America Digital Pathology Market Revenue (US$
Mn) and Forecasts, By Offering
16.6.3.2.1. Software
16.6.3.2.1.1. Pathology
Management System
16.6.3.2.1.2. Laboratory
Information System
16.6.3.2.1.3. Others
16.6.3.2.2. Hardware
16.6.3.2.2.1. Diagnostic
Scanners
16.6.3.2.2.2. Laboratory
Components
16.6.3.2.2.3. Histology
equipment
16.6.3.2.2.4. Others
16.6.3.2.3. Support and Technical services
16.6.3.2.4. Others
16.6.3.3. Rest of Latin America Digital Pathology Market Revenue (US$
Mn) and Forecasts, By Application
16.6.3.3.1. Drug Discovery
16.6.3.3.2. Disease Diagnosis
16.6.3.3.3. Teleconsultation
16.6.3.3.4. Training and Education
16.6.3.3.5. Others
16.6.3.4. Rest of Latin America Digital Pathology Market Revenue (US$
Mn) and Forecasts, By End Users
16.6.3.4.1. Research Institutions
16.6.3.4.2. Pathology Laboratories
16.6.3.4.3. Pharmaceutical and Biotechnology Companies
16.6.3.4.4. Contract Research Organizations
16.6.3.4.5. Academic Medical Centers (Education)
16.6.3.4.6. Clinical Labs
16.6.3.4.7. Geology
16.6.3.4.8. Hospitals
16.6.3.4.9. Others
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By Type
16.7.3. By
Offering
16.7.4. By
Application
16.7.5. By End
Users
17. Competitive Benchmarking
17.1. Market
Share Analysis, 2020
17.2. Global
Presence and Growth Strategies
17.2.1. Mergers
and Acquisitions
17.2.2. Product
Launches
17.2.3. Investments
Trends
17.2.4. R&D
Initiatives
18. Player Profiles
18.1. 3DHISTECH
Ltd.
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. Apollo
Enterprise Imaging Corp.
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. Corista
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. F.
Hoffmann-La Roche Ltd
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Hamamatsu
Photonics K.K.
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. Huron
Technologies International Inc.
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. Indica
Labs
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Koninklijke
Philips N.V.
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Leica
Biosystems Nussloch GmbH
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. OLYMPUS
CORPORATION
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. OptraSCAN
Inc.
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. Proscia
Inc.
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business
Strategies
18.13. Sectra
AB
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business
Strategies
18.14. Visiopharm
A/S
18.14.1. Company
Details
18.14.2. Company
Overview
18.14.3. Product
Offerings
18.14.4. Key
Developments
18.14.5. Financial
Analysis
18.14.6. SWOT
Analysis
18.14.7. Business
Strategies
18.15. XIFIN,
Inc.
18.15.1. Company
Details
18.15.2. Company
Overview
18.15.3. Product
Offerings
18.15.4. Key
Developments
18.15.5. Financial
Analysis
18.15.6. SWOT
Analysis
18.15.7. Business Strategies
18.16. Other
Market Participants
Key Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.